Abstract Background In Japan, iatrogenic acute exacerbation of interstitial lung disease
(ILD) is a serious complication in patients with lung cancer and simultaneous ILD. Results of …

Interstitial lung disease (ILD) and lung cancer are two of the most common respiratory
diseases. The aim of this study was to demonstrate the prognostic significance of the …

Background/Aim: In lung cancer (LC) patients, pre-existing interstitial lung disease (ILD) is a
risk of chemotherapy-associated acute exacerbation of ILD (AE-ILD). AE-ILD shows a …

Background: The clinical features of patients with small cell lung cancer (SCLC) and
idiopathic pulmonary fibrosis (IPF) have not been fully elucidated. Patients and methods …

Introduction It is unknown what type of interstitial lung disease (ILD) has high risk for
chemotherapy-related exacerbation of ILD. We investigated the risk of exacerbation of ILD …

Objective Lung cancer frequently co-exists with idiopathic interstitial pneumonia (IIP), which
can be subdivided into idiopathic pulmonary fibrosis (IPF) and IIP other than IPF (other IIP) …

Background: Idiopathic interstitial pneumonias (IIPs) are among the most common
complications in patients with lung cancer. In such patients with cancer, the most serious …

Background Interstitial lung disease (ILD) is commonly concomitant with lung cancer, and its
acute exacerbation (AE) is the most serious complication in patients receiving treatment for …

Background: The safety and efficacy of second-line chemotherapy for treating patients with
small cell lung cancer (SCLC) and interstitial lung disease (ILD) have not been elucidated to …

Background Idiopathic pulmonary fibrosis (IPF) is associated with an independent increased
risk of lung carcinogenesis. The benefit of chemotherapy for extensive-stage small-cell lung …